Higher concentrations of osteoprotegerin in type 1 diabetic patients are related to retinopathy: Results from the Poznań Prospective Study.

Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
PMID: 29442454

Abstract

BACKGROUND: Osteoprotegerin (OPG) is an arterial calcification marker which has been associated with vascular damage. Elevated OPG concentrations associated with low-grade inflammatory processes are found in diabetic subjects.

Authors

  • Agata Grzelka
    Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poland.
  • Dariusz Naskręt
    Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poland.
  • Aleksandra Araszkiewicz
    Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poland.
  • Aleksandra Uruska
    Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poland.
  • Małgorzata Wegner
    Lipid Metabolism Laboratory, Department of General Chemistry, Chemistry and Clinical Biochemistry, Poznan University of Medical Sciences, Poland.
  • Dorota Zozulińska-Ziółkiewicz
    Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poland.

Keywords

External Resources

Popular Topics
Recent Journals